As per MRFR analysis, the South America Thyroid Disorder Market Size was estimated at 241 (USD Million) in 2024. The South America Thyroid Disorder Market Industry is expected to grow from 353 (USD Million) in 2025 to 522 (USD Million) by 2035. The South America Thyroid Disorder Market CAGR (growth rate) is expected to be around 3.62% during the forecast period (2025 - 2035).
The South America Thyroid Disorder Market is experiencing significant changes driven by a combination of factors. An increasing prevalence of thyroid disorders, such as hypothyroidism and hyperthyroidism, has emerged as a key market driver. Reports indicate a growing awareness and diagnosis of these conditions across the region, partially fueled by improved access to healthcare facilities and diagnostic tools.
As countries like Brazil, Argentina, and Chile advance their healthcare infrastructure, the need for effective thyroid disorder management grows. Furthermore, genetic predisposition and lifestyle factors are contributing to the rise of these disorders in South America. In terms of opportunities to be explored, the demand for innovative treatment solutions offers promising avenues for development.
The market is seeing a shift towards personalized medicine and biologics, which cater to individual patient needs. This trend is increasingly visible in urban areas where patients are more inclined to seek advanced therapeutics. Additionally, ongoing research into alternative therapies, including natural and holistic approaches, represents another space where companies can expand their offerings.
Trends in recent times also highlight a surge in telemedicine services in the region, driven by the COVID-19 pandemic. Patients are opting for virtual appointments for diagnosis and management of thyroid disorders, ensuring continuous care and support. This shift not only enhances patient access but also provides healthcare providers with valuable data insights.
Overall, the South America Thyroid Disorder Market showcases a dynamic environment driven by increased awareness, technological advances, and a growing emphasis on patient-centered care
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The South America Thyroid Disorder Market Industry is significantly driven by the rising prevalence of thyroid disorders across the region. According to the Ministry of Health of Brazil, thyroid diseases, particularly hypothyroidism, affect approximately 10% of the population, translating to around 21 million individuals in Brazil alone. This high prevalence rate indicates a growing patient pool requiring medical attention and treatment options for thyroid disorders.
Moreover, the growing awareness of thyroid health and the effort to improve screening programs in South American countries, such as Argentina and Colombia, contribute to earlier diagnosis and treatment. Established organizations like the Brazilian Society of Endocrinology and Metabolism are actively promoting awareness campaigns, which has a notable impact on driving the demand for thyroid disorder therapies and diagnostics across South America.
The South America Thyroid Disorder Market Industry is witnessing growth due to advancements in diagnostic technologies. Innovations such as highly sensitive thyroid function tests and the introduction of molecular diagnostics play a crucial role in enhancing diagnosis accuracy and speed. A report from the Argentine Ministry of Health indicated a 25% increase in the accuracy of thyroid testing due to the recent adoption of advanced technologies in laboratory settings.
Besides, groups like the World Health Organization have highlighted the need for sophisticated and streamlined laboratory services for thyroid disorder diagnosis, which improves treatment pathways. These advancements in technology not only make timely treatment intervention easier but also aid in expanding the market.
Another driving factor for the South America Thyroid Disorder Market Industry is the increasing health expenditure across various South American nations. Reports indicate that health expenditure has been rising at an average rate of 5-7% annually, with several countries such as Chile and Uruguay investing heavily in healthcare services, including endocrinology.
According to Chile's Ministry of Health, health spending is expected to reach approximately 10.2% of the country's GDP by 2025, emphasizing the commitment to improving healthcare infrastructure. This surge in health expenditure reflects the growing prioritization of health issues, including thyroid disorders, leading to enhanced funding for research, diagnostics, and treatment modalities by public and private sectors alike.
The South America Thyroid Disorder Market is categorized into key types including Hypothyroidism and Hyperthyroidism, which play crucial roles in the region's healthcare landscape. Hypothyroidism, characterized by an underactive thyroid, significantly impacts the lives of many individuals, particularly women, making it one of the most prevalent thyroid-related disorders in South America.
This segment has been gaining attention due to the increasing awareness about thyroid health and its association with various health issues such as obesity and cardiovascular risk. As healthcare systems in South America continue to enhance screening measures and improve patient education, the prevalence of hypothyroidism is expected to grow, driving demand for various treatment options.
On the other hand, Hyperthyroidism is another significant type within the South America Thyroid Disorder Market, which occurs due to an overactive thyroid gland. This condition typically leads to symptoms such as weight loss, anxiety, and increased heart rate. The growing occurrence of hyperthyroidism, particularly in urban populations due to lifestyle changes and environmental factors, illustrates the need for widespread diagnosis and management solutions.
Both segments are interlinked, as effective management of thyroid disorders requires comprehensive approaches encompassing medication, lifestyle changes, and regular monitoring. The growing emphasis on preventive healthcare and advances in treatment alternatives present opportunities for healthcare providers and pharmaceutical companies in South America to address the critical needs of patients suffering from these thyroid conditions.
Overall, the focus on awareness, early diagnosis, and innovative treatment options continues to shape the South America Thyroid Disorder Market, showcasing the importance of both Hypothyroidism and Hyperthyroidism in the region's health dynamics.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The Treatment segment of the South America Thyroid Disorder Market encompasses various methodologies including Medications, Radioactive Iodine Therapy, and Surgery, playing a pivotal role in managing thyroid disorders prevalent in the region. With a growing awareness of thyroid health, patient access to innovative treatment options is increasing, leading to a rise in utilization.
Medications are crucial as they directly address hormone imbalances, becoming a primary choice for many patients managing conditions such as hypothyroidism and hyperthyroidism. Radioactive Iodine Therapy is significant in treating hyperthyroidism and specific thyroid cancers, with its effectiveness driving demand in clinical practices.
Moreover, Surgery remains a vital option, especially in cases of large goiters or malignancies, as it provides definitive solutions for patients needing long-term management. The South America Thyroid Disorder Market is experiencing a steady evolution, influenced by advancements in medical technology and growing healthcare infrastructure.
Additionally, as the prevalence of thyroid disorders rises, there are opportunities for innovative treatments and personalized medicine approaches, reflecting changing patient needs. Overall, the Treatment segment is essential for addressing the needs of patients and improving thyroid health outcomes across South America.
The Route of Administration segment in the South America Thyroid Disorder Market plays a crucial role in determining treatment effectiveness and patient compliance. Oral administration is often favored for thyroid hormone replacement therapies due to its convenience and ease of use, thus establishing a strong foothold in the market.
Intravenous administration, meanwhile, is essential for acute management scenarios, particularly in cases where immediate therapeutic action is required. Other routes, such as subcutaneous and intramuscular options, complement these methods, providing alternative avenues for therapy in specific patient populations.
The market is characterized by an increasing demand for effective and patient-friendly delivery options, driven by rising awareness and diagnosis of thyroid disorders in South America. Additionally, ongoing advancements in pharmaceutical formulations are aimed at improving bioavailability and patient adherence, thereby enhancing overall treatment outcomes.
As the South America Thyroid Disorder Market continues to grow, the focus on refining routes of administration remains pivotal, supporting broader market dynamics and healthcare practices in the region.
The ser segment of the South America Thyroid Disorder Market plays a crucial role in delivering healthcare solutions to patients suffering from thyroid-related problems. With a growing emphasis on early diagnosis and effective treatment, hospitals and healthcare clinics are increasingly equipped to handle thyroid disorders, offering specialized services and advanced technologies.
Hospitals often dominate this segment due to their comprehensive facilities and access to multidisciplinary teams. Clinics, on the other hand, provide more personalized care and convenience for patients seeking thyroid evaluation and treatment, thereby gaining significant traction.
Moreover, other healthcare providers, such as outpatient facilities and telehealth services, are emerging to cater to the expanding patient base in South America. This diversification allows patients various options, making treatment more accessible. The rising awareness regarding thyroid disorders, coupled with increasing healthcare expenditure, drives the demand for these services.
In addition, the ongoing developments in healthcare infrastructure in countries like Brazil and Argentina are expected to bolster the growth of this segment, making it an integral part of the overall South America Thyroid Disorder Market statistics.
The South America Thyroid Disorder Market is characterized by a diverse set of conditions across its various regions, significantly impacting healthcare policies and practices. Brazil holds a dominant position, reflecting a high prevalence of thyroid disorders influenced by urbanization and lifestyle changes.
Mexico ranks next, where healthcare access and awareness are steadily improving, leading to an increasing diagnosis of thyroid issues. Argentina showcases a growing recognition of thyroid health, propelled by governmental health initiatives aiming to educate the public and improve early detection.
Meanwhile, the Rest of South America segment benefits from regional collaborations and advancements in medical technology that enhance diagnosis and treatment. Overall, these regions present a substantial opportunity for growth, driven by rising healthcare expenditure, increasing incidence rates, and the development of new therapeutic options for managing thyroid disorders.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The South America Thyroid Disorder Market is witnessing notable competitive dynamics as the region grapples with a rising incidence of thyroid disorders, including hypothyroidism and hyperthyroidism, which has propelled demand for effective diagnostics and therapeutics.
The competitive landscape consists of various global and local companies seeking to enhance their market share through innovative products, strategic collaborations, and expanding distribution networks. As the healthcare infrastructure in South America evolves, companies are increasingly focusing on tailored treatment options and improving access to their products across diverse geographical areas.
With a growing emphasis on patient health outcomes, the market's competitive insights reflect the importance of understanding regional needs, regulatory environments, and consumer preferences for thyroid-related healthcare.
GlaxoSmithKline has carved a significant presence in the South America Thyroid Disorder Market by leveraging its extensive portfolio of therapeutic options targeted at managing thyroid conditions. The company’s strengths include robust research and development capabilities, enabling the introduction of innovative treatments that meet the specific needs of the South American population.
By focusing on partnerships with local healthcare institutions and facilitating training programs for healthcare professionals, GlaxoSmithKline enhances the quality of thyroid care in the region. The company's strategic commitment to addressing local health challenges, coupled with its established distribution channels, positions it as a key player in meeting the needs of patients with thyroid disorders across South America.
BristolMyers Squibb has also established its foothold in the South America Thyroid Disorder Market with its diverse range of products aimed at treating thyroid dysfunction. The company’s key offerings include both traditional pharmaceutical solutions and novel therapeutic approaches addressing thyroid disorders.
Its strengths lie in its innovative research and significant investment in local collaborations, which allow for the expedited development and distribution of its products. BristolMyers Squibb is known for its strategic mergers and acquisitions, enhancing its capabilities and service offerings in the region.
This approach not only strengthens its product pipeline but also improves its market presence in South America, ensuring that patients have better access to the necessary therapies for thyroid disorders. The company's commitment to improving patient outcomes further solidifies its position within the competitive landscape of the region's thyroid disorder market.
Recent developments in the South America Thyroid Disorder Market have highlighted a growing focus on enhancing treatment options and expanding the availability of medication. Companies such as GlaxoSmithKline, Bristol-Myers Squibb, and Eli Lilly and Company are actively engaged in research to develop innovative therapies tailored to the specific needs of South American patients.
Notably, in September 2023, Takeda Pharmaceutical Company announced a partnership to enhance the distribution of thyroid-related medications across Brazil, addressing the increasing demand for hyperthyroid and hypothyroid treatments. The market has seen substantial growth, with analysts predicting a rise in valuation attributed to improved healthcare infrastructure and rising healthcare awareness.
Additionally, in August 2023, Roche Holding AG made significant strides in improving diagnostic interventions for thyroid disorders, marking a critical step toward personalized medicine in this region. Over the last couple of years, Amgen Inc. and Sanofi also made efforts to establish local partnerships to streamline clinical trials and expedite approvals for new therapies.
These initiatives reflect a continuous effort to tackle thyroid disorders effectively and provide better healthcare solutions in South America.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 241.0(USD Million) |
| MARKET SIZE 2024 | 353.0(USD Million) |
| MARKET SIZE 2035 | 522.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 3.62% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | GlaxoSmithKline, BristolMyers Squibb, Eli Lilly and Company, Takeda Pharmaceutical Company, Abbott Laboratories, Amgen Inc., Teva Pharmaceutical Industries, Sanofi, Merck KGaA, Pfizer Inc., Boehringer Ingelheim, Roche Holding AG, AstraZeneca, Johnson & Johnson, Novartis AG |
| SEGMENTS COVERED | Type, Treatment, Route of Administration, End User, Regional |
| KEY MARKET OPPORTUNITIES | Rising prevalence of thyroid disorders, Growing awareness and education initiatives, Expansion of diagnostic testing services, Increasing telemedicine adoption, Advancements in treatment options and technologies |
| KEY MARKET DYNAMICS | increasing prevalence of thyroid disorders, growing awareness and diagnosis, advancements in treatment options, rising healthcare expenditure, government support for healthcare initiatives |
| COUNTRIES COVERED | Brazil, Mexico, Argentina, Rest of South America |
Frequently Asked Questions (FAQ) :
The South America Thyroid Disorder Market is expected to be valued at 353.0 million USD in 2024.
By 2035, the South America Thyroid Disorder Market is projected to reach a value of 522.0 million USD.
The expected CAGR for the South America Thyroid Disorder Market from 2025 to 2035 is 3.62%.
Brazil is expected to hold the largest market share, valued at 150.0 million USD in 2024.
The Hypothyroidism segment is valued at 212.0 million USD in 2024 within the South America Thyroid Disorder Market.
The Hyperthyroidism segment is projected to reach 213.0 million USD in 2035.
Key players include GlaxoSmithKline, Eli Lilly and Company, and Pfizer Inc., among others.
The Thyroid Disorder Market in Mexico is expected to grow from 85.0 million USD in 2024 to 125.0 million USD in 2035.
By 2035, the South America Thyroid Disorder Market value for Argentina is expected to be 90.0 million USD.
The main growth drivers include increasing prevalence of thyroid disorders and advancements in healthcare technology.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Analyst Explore the profile of garvit vyas, one of our esteemed authors at market research future, and access their expert research contributions in the field of market research and industry analysis
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
